BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Angata T. Siglec-15: a potential regulator of osteoporosis, cancer, and infectious diseases. J Biomed Sci 2020;27:10. [PMID: 31900164 DOI: 10.1186/s12929-019-0610-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Ronit A, Jørgensen SE, Roed C, Eriksson R, Iepsen UW, Plovsing RR, Storgaard M, Gustafsson F, Hansen AE, Mogensen TH. Host Genetics and Antiviral Immune Responses in Adult Patients With Multisystem Inflammatory Syndrome. Front Immunol 2021;12:718744. [PMID: 34531865 DOI: 10.3389/fimmu.2021.718744] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Murugesan G, Correia VG, Palma AS, Chai W, Li C, Feizi T, Martin E, Laux B, Franz A, Fuchs K, Weigle B, Crocker PR. Siglec-15 recognition of sialoglycans on tumor cell lines can occur independently of sialyl Tn antigen expression. Glycobiology 2021;31:44-54. [PMID: 32501471 DOI: 10.1093/glycob/cwaa048] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
3 Sirufo MM, De Pietro F, Bassino EM, Ginaldi L, De Martinis M. Osteoporosis in Skin Diseases. Int J Mol Sci 2020;21:E4749. [PMID: 32635380 DOI: 10.3390/ijms21134749] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
4 Anwar MT, Kawade SK, Huo Y, Adak AK, Sridharan D, Kuo Y, Fan C, Wu H, Lee Y, Angata T, Lin C. Sugar nucleotide regeneration system for the synthesis of Bi- and triantennary N-glycans and exploring their activities against siglecs. European Journal of Medicinal Chemistry 2022. [DOI: 10.1016/j.ejmech.2022.114146] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Xiao X, Peng Y, Wang Z, Zhang L, Yang T, Sun Y, Chen Y, Zhang W, Chang X, Huang W, Tian S, Feng Z, Xinhua N, Tang Q, Mao Y. A novel immune checkpoint siglec-15 antibody inhibits LUAD by modulating mφ polarization in TME. Pharmacol Res 2022;:106269. [PMID: 35605813 DOI: 10.1016/j.phrs.2022.106269] [Reference Citation Analysis]
6 Yang D, Yang L, Cai J, Hu X, Li H, Zhang X, Zhang X, Chen X, Dong H, Nie H, Li Y. A sweet spot for macrophages: Focusing on polarization. Pharmacol Res 2021;167:105576. [PMID: 33771700 DOI: 10.1016/j.phrs.2021.105576] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 Liu W, Ji Z, Wu B, Huang S, Chen Q, Chen X, Wei Y, Jiang J. Siglec-15 promotes the migration of liver cancer cells by repressing lysosomal degradation of CD44. FEBS Lett 2021. [PMID: 34328657 DOI: 10.1002/1873-3468.14169] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Hou X, Chen C, He X, Lan X, Shi Z. Siglec-15 Silencing Inhibits Cell Proliferation and Promotes Cell Apoptosis by Inhibiting STAT1/STAT3 Signaling in Anaplastic Thyroid Carcinoma. Disease Markers 2022;2022:1-16. [DOI: 10.1155/2022/1606404] [Reference Citation Analysis]
9 Jiang KY, Qi LL, Kang FB, Wang L. The intriguing roles of Siglec family members in the tumor microenvironment. Biomark Res 2022;10:22. [PMID: 35418152 DOI: 10.1186/s40364-022-00369-1] [Reference Citation Analysis]
10 Korn MA, Schmitt H, Angermüller S, Chambers D, Seeling M, Lux UT, Brey S, Royzman D, Brückner C, Popp V, Percivalle E, Bäuerle T, Zinser E, Winkler TH, Steinkasserer A, Nimmerjahn F, Nitschke L. Siglec-15 on Osteoclasts Is Crucial for Bone Erosion in Serum-Transfer Arthritis. J Immunol 2020;205:2595-605. [PMID: 33020147 DOI: 10.4049/jimmunol.2000472] [Reference Citation Analysis]
11 Yoo YJ, Kim AR, Perinpanayagam H, Han SH, Kum KY. Candida albicans Virulence Factors and Pathogenicity for Endodontic Infections. Microorganisms 2020;8:E1300. [PMID: 32858856 DOI: 10.3390/microorganisms8091300] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
12 Lenza MP, Atxabal U, Oyenarte I, Jiménez-Barbero J, Ereño-Orbea J. Current Status on Therapeutic Molecules Targeting Siglec Receptors. Cells 2020;9:E2691. [PMID: 33333862 DOI: 10.3390/cells9122691] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
13 Mansorunov D, Apanovich N, Apanovich P, Kipkeeva F, Muzaffarova T, Kuzevanova A, Nikulin M, Malikhova O, Karpukhin A. Expression of Immune Checkpoints in Malignant Tumors: Therapy Targets and Biomarkers for the Gastric Cancer Prognosis. Diagnostics (Basel) 2021;11:2370. [PMID: 34943606 DOI: 10.3390/diagnostics11122370] [Reference Citation Analysis]
14 Dufrançais O, Mascarau R, Poincloux R, Maridonneau-Parini I, Raynaud-Messina B, Vérollet C. Cellular and molecular actors of myeloid cell fusion: podosomes and tunneling nanotubes call the tune. Cell Mol Life Sci 2021. [PMID: 34296319 DOI: 10.1007/s00018-021-03875-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Movsisyan LD, Macauley MS. Structural advances of Siglecs: insight into synthetic glycan ligands for immunomodulation. Org Biomol Chem 2020;18:5784-97. [PMID: 32756649 DOI: 10.1039/d0ob01116a] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
16 Kamath V. Cancer vaccines: An unkept promise? Drug Discov Today 2021;26:1347-52. [PMID: 33601016 DOI: 10.1016/j.drudis.2021.02.006] [Reference Citation Analysis]